Dyadic International, Inc. (DYAI)
0.3401
-0.03
(-7.25%)
USD |
NASDAQ |
Nov 05, 16:00
Dyadic International Enterprise Value : 12.77M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 12.77M |
| November 04, 2026 | 13.74M |
| November 03, 2026 | 13.49M |
| November 02, 2026 | 14.08M |
| October 30, 2026 | 14.23M |
| October 29, 2026 | 13.53M |
| October 28, 2026 | 14.74M |
| October 27, 2026 | 14.69M |
| October 26, 2026 | 15.54M |
| October 23, 2026 | 14.92M |
| October 22, 2026 | 15.03M |
| October 21, 2026 | 14.95M |
| October 20, 2026 | 14.41M |
| October 19, 2026 | 14.26M |
| October 16, 2026 | 15.36M |
| October 15, 2026 | 15.66M |
| October 14, 2026 | 15.32M |
| October 13, 2026 | 15.87M |
| October 12, 2026 | 15.72M |
| October 09, 2026 | 16.56M |
| October 08, 2026 | 16.57M |
| October 07, 2026 | 17.01M |
| October 06, 2026 | 16.89M |
| October 05, 2026 | 16.92M |
| October 02, 2026 | 16.99M |
| Date | Value |
|---|---|
| October 01, 2026 | 16.03M |
| September 30, 2026 | 16.58M |
| September 29, 2026 | 17.36M |
| September 28, 2026 | 17.32M |
| September 25, 2026 | 15.54M |
| September 24, 2026 | 16.23M |
| September 23, 2026 | 15.50M |
| September 22, 2026 | 14.95M |
| September 21, 2026 | 14.99M |
| September 18, 2026 | 15.50M |
| September 17, 2026 | 15.82M |
| September 16, 2026 | 15.05M |
| September 15, 2026 | 15.97M |
| September 14, 2026 | 15.84M |
| September 11, 2026 | 18.01M |
| September 10, 2026 | 18.22M |
| September 09, 2026 | 19.10M |
| September 08, 2026 | 19.33M |
| September 04, 2026 | 19.33M |
| September 03, 2026 | 18.62M |
| September 02, 2026 | 19.48M |
| September 01, 2026 | 19.77M |
| August 31, 2026 | 20.60M |
| August 28, 2026 | 22.75M |
| August 27, 2026 | 23.66M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 539.10M |
| Amgen, Inc. | 289.78B |
| Anika Therapeutics, Inc. | 245.53M |
| BioCryst Pharmaceuticals, Inc. | 2.407B |
| Imunon, Inc. | 5.181M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.124M |
| Revenue (Quarterly) | 0.9611M |
| Total Expenses (Quarterly) | 3.085M |
| EPS Diluted (Quarterly) | -0.0583 |
| Gross Profit Margin (Quarterly) | -2.39% |
| Profit Margin (Quarterly) | -221.0% |
| Earnings Yield | -62.51% |
| Normalized Earnings Yield | -62.51 |